FDA Inspection
Alexander E. Horwitz, III, M.D.Alexander E. Horwitz, III, M.D. – FDA Inspection, Nov 14, 2014
Record Details
This FDA Inspection record concerns Alexander E. Horwitz, III, M.D., with an inspection on November 14, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 14, 2014
- Product Type
- Drugs
View Company Profile
ID · 588092c3-ff5b-4618-a5c0-b7fa954c71f1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 903151
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alexander E. Horwitz, III, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 2, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 14, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Alexander E. Horwitz, III, M.D.
- FDA Inspection 1192948 - 2022-10-28
- FDA Inspection 898617 - 2014-10-02
- FDA Inspection 813526 - 2012-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.